- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in Membranous Nephropathy
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 10, Issue 4, Pages 607
Publisher
MDPI AG
Online
2021-02-08
DOI
10.3390/jcm10040607
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Patients with Membranous Lupus Nephritis, Exostosin-Positivity and Exostosin-Negativity Represent Two Different Phenotypes
- (2021) Aishwarya Ravindran et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Screening for Cancer in Patients with Glomerular Diseases
- (2020) Emmanuelle Plaisier et al. Clinical Journal of the American Society of Nephrology
- Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives
- (2020) Etienne Crickx et al. KIDNEY INTERNATIONAL
- Successful Treatment of Patients With Refractory PLA2R-Associated Membranous Nephropathy With Obinutuzumab: A Report of 3 Cases
- (2020) Nattawat Klomjit et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase 2b trial
- (2020) Matthieu Mahévas et al. HAEMATOLOGICA
- Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients.
- (2020) Sanjeev Sethi et al. KIDNEY INTERNATIONAL
- The clinicopathologic spectrum of segmental membranous glomerulopathy.
- (2020) Satoru Kudose et al. KIDNEY INTERNATIONAL
- Membranous Nephropathy Associated With Indigenous Indian Medications Containing Heavy Metals
- (2020) M. Naveen Kumar et al. Kidney International Reports
- Successful treatment of PLA2R1-antibody positive membranous nephropathy with ocrelizumab
- (2020) Tilman Schmidt et al. JOURNAL OF NEPHROLOGY
- NELL1 is a target antigen in malignancy-associated membranous nephropathy
- (2020) Tiffany Caza et al. KIDNEY INTERNATIONAL
- Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis.
- (2020) Tiffany Caza et al. KIDNEY INTERNATIONAL
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
- (2020) Richard Furie et al. NEW ENGLAND JOURNAL OF MEDICINE
- The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
- (2020) Gema Fernández-Juárez et al. KIDNEY INTERNATIONAL
- Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy
- (2019) Christelle Zaghrini et al. KIDNEY INTERNATIONAL
- Exostosin 1/Exostosin 2–Associated Membranous Nephropathy
- (2019) Sanjeev Sethi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Diagnostic role of renal biopsy in PLA2R1-antibody-positive patients with nephrotic syndrome
- (2019) Thorsten Wiech et al. MODERN PATHOLOGY
- High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy
- (2019) Barbara Seitz-Polski et al. Clinical Journal of the American Society of Nephrology
- Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy
- (2019) Christine Barrett et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
- (2019) Fernando C. Fervenza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of Membranous Nephropathy in Patients With THSD7A Antibodies Using Immunoadsorption
- (2019) Julia Weinmann-Menke et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery
- (2019) Anne-Els van de Logt et al. KIDNEY INTERNATIONAL
- Nell-1 Is a Key Functional Modulator in Osteochondrogenesis and Beyond
- (2019) C. Li et al. JOURNAL OF DENTAL RESEARCH
- Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy
- (2019) Sanjeev Sethi et al. KIDNEY INTERNATIONAL
- Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab
- (2018) Anne-Els van de Logt et al. KIDNEY INTERNATIONAL
- Rapid detection of urinary soluble intercellular adhesion molecule-1 for determination of lupus nephritis activity
- (2018) Yanyun Wang et al. MEDICINE
- Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis
- (2018) Stephen P McAdoo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Retreatment with rituximab for membranous nephropathy with persistently elevated titers of anti-phospholipase A2 receptor antibody
- (2018) K. Dahan et al. KIDNEY INTERNATIONAL
- Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy
- (2017) Jan A.J.G. van den Brand et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Intravenous pulse cyclophosphamide and steroids induce immunological and clinical remission in New-incident and relapsing primary membranous nephropathy
- (2017) Durga Anil K Kanigicherla et al. NEPHROLOGY
- Current insights into functions of phospholipase A2 receptor in normal and cancer cells: More questions than answers
- (2017) Olga Sukocheva et al. SEMINARS IN CANCER BIOLOGY
- Membranous Nephropathy: Quantifying Remission Duration on Outcome
- (2016) Daniel C. Cattran et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Proposal for a Serology-Based Approach to Membranous Nephropathy
- (2016) An S. De Vriese et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
- (2016) Karine Dahan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Mechanism for Cancer-Associated Membranous Nephropathy
- (2016) Elion Hoxha et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy
- (2015) P. Ruggenenti et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pathophysiological advances in membranous nephropathy: time for a shift in patient's care
- (2015) Pierre Ronco et al. LANCET
- Phospholipase A2 receptor and sarcoidosis-associated membranous nephropathy
- (2015) Thomas Stehlé et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Cancer Risk after Cyclophosphamide Treatment in Idiopathic Membranous Nephropathy
- (2014) J. A. J. G. van den Brand et al. Clinical Journal of the American Society of Nephrology
- Phospholipase A2 Receptor Autoantibodies and Clinical Outcome in Patients with Primary Membranous Nephropathy
- (2014) E. Hoxha et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy
- (2014) Nicola M. Tomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Diagnosis Accuracy of PLA2R-AB in the Diagnosis of Idiopathic Membranous Nephropathy: A Meta-Analysis
- (2014) Yu Du et al. PLoS One
- Antiphospholipase A2Receptor Autoantibodies: A Comparison of Three Different Immunoassays for the Diagnosis of Idiopathic Membranous Nephropathy
- (2014) Astrid Behnert et al. Journal of Immunology Research
- Proteomic analysis of podocyte exosome-enriched fraction from normal human urine
- (2013) Marco Prunotto et al. Journal of Proteomics
- The extostosin family: Proteins with many functions
- (2013) Marta Busse-Wicher et al. MATRIX BIOLOGY
- Spontaneous Remission of Nephrotic Syndrome in Idiopathic Membranous Nephropathy
- (2010) N. Polanco et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone
- (2009) M. Eriguchi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous Nephropathy
- (2009) Laurence H. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started